Literature DB >> 940755

[Management following mammography revealing grouped microcalcifications without palpable tumor].

M Le Gal, J C Durand, M Laurent, D Pellier.   

Abstract

On the basis of a series of 60 cases, the authors report their experience of excision of grouped microcalcifications detected at mammography in the absence of any clinical sign. The breast zone in which the microcalcifications were located by the radiologist was removed surgically. Per-operatoire X-ray of the excised specimens using a mammography apparatus confirmed that the microcalcifications had been totally removed. In addition it was useful to locate aceuretaly the calcifications in view of a careful histological examination of the area. The technique led to the discovery of 27 carcinomas at a sub-clinical stage. A classification of the various types of microcalcification was established in relation to histology. It will be of assistance in suspecting malignancy on the basis of mammography findings in the majority of cases. Excision can then be reserved for cases of presumed malignancy or where a doubt exists. By detecting breast carcinomas at a sub-clinical stage, the method makes possible early and minimally mutilating treatment with the best chances of cure.

Entities:  

Mesh:

Year:  1976        PMID: 940755

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  2 in total

1.  Different types of microcalcifications observed in breast pathology. Correlations with histopathological diagnosis and radiological examination of operative specimens.

Authors:  L Frappart; I Remy; H C Lin; A Bremond; D Raudrant; B Grousson; J L Vauzelle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  "Hippocrates-mst": a prototype for computer-aided microcalcification analysis and risk assessment for breast cancer.

Authors:  George Spyrou; Smaragda Kapsimalakou; Antonis Frigas; Konstantinos Koufopoulos; Stamatios Vassilaros; Panos Ligomenides
Journal:  Med Biol Eng Comput       Date:  2006-10-27       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.